Patents by Inventor Yi-Mi Wu

Yi-Mi Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating cancer
    Patent number: 11746151
    Abstract: Provided herein are compositions and methods for treating cancer. In particular, provided herein are compositions, methods, and uses of targeted therapy to treat cancer (e.g., prostate cancer) in subjects with CDK12 mutations.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: September 5, 2023
    Assignee: The Regents of the University of Michigan
    Inventors: Arul Chinnaiyan, Dan Robinson, Yi-Mi Wu, Marcin Cieslik
  • Systems and methods for determining a treatment course of action
    Patent number: 11697852
    Abstract: The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: July 11, 2023
    Assignee: The Regents of the University of Michigan
    Inventors: Arul M. Chinnaiyan, Dan Robinson, Yi-Mi Wu
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20210155695
    Abstract: Provided herein are compositions and methods for treating cancer. In particular, provided herein are compositions, methods, and uses of targeted therapy to treat cancer (e.g., prostate cancer) in subjects with CDK12 mutations.
    Type: Application
    Filed: April 12, 2019
    Publication date: May 27, 2021
    Inventors: Arul CHINNAIYAN, Dan ROBINSON, Yi-Mi WU, Marcin CIESLIK
  • SYSTEMS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION
    Publication number: 20190271045
    Abstract: The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
    Type: Application
    Filed: January 7, 2019
    Publication date: September 5, 2019
    Inventors: Arul M. Chinnaiyan, Dan Robinson, Yi-Mi Wu
  • Systems and methods for determining a treatment course of action
    Patent number: 10174381
    Abstract: The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: January 8, 2019
    Assignee: The Regents of the University of Michigan
    Inventors: Arul M. Chinnaiyan, Dan Robinson, Yi-Mi Wu
  • Recurrent gene fusions in cancer
    Patent number: 9783853
    Abstract: The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to gene fusions as diagnostic markers and clinical targets for cancer.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: October 10, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, Yi-Mi Wu, Dan Robinson
  • SYSTEMS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION
    Publication number: 20150141391
    Abstract: The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
    Type: Application
    Filed: October 14, 2014
    Publication date: May 21, 2015
    Inventors: Arul M. Chinnaiyan, Dan Robinson, Yi-Mi Wu
  • RECURRENT GENE FUSIONS IN CANCER
    Publication number: 20150017637
    Abstract: The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to gene fusions as diagnostic markers and clinical targets for cancer.
    Type: Application
    Filed: July 11, 2014
    Publication date: January 15, 2015
    Inventors: Arul Chinnaiyan, Yi-Mi Wu, Dan Robinson